Previous studies have investigated the prognostic influence of chemotherapy drugs, including erlotinib, gefitinib [16] and epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKI) [17, 18], on NSCLC using nomograms. Here, EGFR is linked to non-small cell lung carcinoma.